Relevantly, the treatment of osteosarcoma CSCs with cinobufagin, a steroid lactone used in Chinese medicine, was able to reduce their levels of IL-6, p-STAT3 and OPN, resulting in an attenuated stem-like phenotype and decreased tumor growth [75]. The gene discussed is SPP1; the disease is osteosarcoma.